Login to Your Account



ReNeuron's Backers Taking It Private In Face Of Cash Crunch

By Nuala Moran


Wednesday, April 2, 2003
ReNeuron Holdings plc, the UK's only quoted stem cell company, is being taken private by its venture capital backers, the Merlin Consortium, in a recommended cash offer of 10 pence per share, valuing ReNeuron at £3.6 million (US$5.7 million). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription